Role of rLH on controlled ovarian hyperstimulation (COH) in IVF

被引:0
|
作者
Ferraretti, A. P. [1 ]
Kopcow, L. [2 ]
Feliciani, E. [1 ]
Magli, M. C. [1 ]
Gergolet, M. [1 ]
Fortini, D. [1 ]
Cetera, C. [3 ]
Gianaroli, L. [1 ]
机构
[1] SISMER, Reprod Med Unit, Bologna, Italy
[2] IFER, Reprod Med Unit, Buenos Aires, DF, Argentina
[3] Osped Civile, Unit Obstet & Gynecol, Pieve Di Cadore, Italy
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:114 / 114
页数:1
相关论文
共 50 条
  • [1] Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF)
    Shanbhag, S.
    Aucott, L.
    Bhattacharya, S.
    Hamilton, M. A.
    McTavish, A. R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [2] Serum FSH Levels During Controlled Ovarian Hyperstimulation (COH) Predict IVF Success.
    Perlman, Barry
    Kulak, David
    Buyuk, Erkan
    McGovern, Peter G.
    [J]. REPRODUCTIVE SCIENCES, 2016, 23 : 260A - 260A
  • [3] Is rapid follicular development during controlled ovarian hyperstimulation (COH) for IVF and ICSI detrimental to success rate?
    Ghobara, T
    Vandekerckhove, P
    Kennedy, R
    [J]. FERTILITY AND STERILITY, 2002, 78 (03) : S20 - S20
  • [4] Beneficial use of ganirelix in controlled ovarian hyperstimulation (COH) cycles in older women undergoing in vitro fertilization (IVF).
    Jurema, MW
    Posada, MN
    Bracero, NJ
    Vlahos, NP
    Garcia, JE
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : S130 - S130
  • [5] Intramural leiomyomata which enlarge during controlled ovarian hyperstimulation (COH) for IVF have individual characteristics.
    Zeyneloglu, HB
    Ozdemir, BH
    Haydardedeoglu, B
    Batioglu, SA
    [J]. FERTILITY AND STERILITY, 2002, 78 (03) : S156 - S157
  • [6] Comparison of GnRH agonist and antagonist protocols for controlled ovarian hyperstimulation (COH) in poor response IVF patients.
    Winston, NJ
    Puccini, M
    Nelson, L
    Scoccia, H
    [J]. FERTILITY AND STERILITY, 2004, 82 : S123 - S124
  • [7] Machine Learning approaches to Predicting Personalized Response to Controlled Ovarian Hyperstimulation (COH) During In Vitro Fertilization (IVF).
    Thukral, S.
    Sakkas, D.
    Vaughan, D. A.
    Toth, T. L.
    Penzias, A. S.
    Bhasin, S.
    Jasuja, R.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 425 - 426
  • [8] Liver and kidney function of patients undergoing to a controlled ovarian hyperstimulation (COH) during an in vitro fertilization (IVF) cycle
    Romito, Ilaria
    Gulino, Ferdinando A.
    Tuscano, Attilio
    Di Gregorio, L. M.
    Di Stefano, A.
    Leanza, Gianluca
    Leanza, Vito
    Palumbo, Marco A.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 146 - 146
  • [9] CONTROLLED OVARIAN HYPERSTIMULATION AND IVF PREGNANCY PROGNOSIS
    Enache, Andreea
    Marinescu, B.
    Enache, T.
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (02): : 414 - 423
  • [10] Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles
    Mochtar, M. H.
    Van der Veen
    Ziech, M.
    van Wely, M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):